Filing Analysis
RetinalGenix Technologies Inc. announced the resignation of its independent auditor, Liebman Hymowitz, LLP, and the simultaneous appointment of Vilki & Co., Charted Accountants. The outgoing auditor's previous reports included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
🚩 Red Flags
- Auditor change combined with existing going concern language.
- Presence of an explanatory paragraph in previous audits regarding substantial doubt about ability to continue as a going concern.
- Rapid replacement of auditor (resignation July 13, new appointment July 15).
📋 Key Facts
- Liebman Hymowitz, LLP (LH) resigned effective July 13, 2026.
- Vilki & Co., Charted Accountants appointed as new auditor effective July 15, 2026.
- Previous audit reports for FY2024 and FY2025 included an explanatory paragraph regarding 'substantial doubt about the Company's ability to continue as a going concern'.
- No disagreements on accounting principles or auditing scope were reported by the outgoing auditor.
RetinalGenix Technologies Inc. amended an existing Pre-Funded Common Stock Purchase Warrant held by Sanovas Ophthalmology, LLC. The amendment introduces significant restrictions on the timing of warrant exercise.
🚩 Red Flags
- Large volume of potential dilution (28,014,540 shares) currently held by a single entity.
- The restriction on exercise is tied to 'uplisting,' suggesting the company is currently trading on a lower-tier exchange or OTC.
📋 Key Facts
- Amendment to a Pre-Funded Common Stock Purchase Warrant dated December 27, 2021.
- The warrant covers 28,014,540 shares of common stock held by Sanovas Ophthalmology, LLC.
- Exercise restriction: The warrant cannot be exercised until the earlier of February 1, 2030, or the third anniversary of the Company's uplisting to Nasdaq or NYSE American.
The Delaware Court of Chancery has issued an order voiding and cancelling 3,000,000 shares of Series F Preferred Stock previously issued to Halo Management LLC in 2018. This follows a 2021 Board resolution to rescind the shares due to lack of contract consideration.
🚩 Red Flags
- Legal dispute/litigation involving share issuance and contract consideration.
- Historical governance issue regarding 'lack of contract consideration' for preferred stock.
📋 Key Facts
- Court Order Date: April 2, 2024
- Action: Voiding and cancelling 3,000,000 shares of Series F Preferred Stock.
- Recipient of cancelled shares: Halo Management LLC.
- Original Issuance Year: 2018.
- Reason for rescission: Lack of contract consideration (as per Board resolution on Nov 21, 2021).
- Accounting Treatment: The Company already recorded the rescission in its Q4 2021 accounts.